| Original language | English (US) |
|---|---|
| Pages (from-to) | 2126-2127 |
| Number of pages | 2 |
| Journal | Neurology |
| Volume | 89 |
| Issue number | 21 |
| DOIs | |
| State | Published - 2017 |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Neurofilaments in blood : (Almost) facing clinical application. / Mielke, Michelle M.; Otto, Markus.
In: Neurology, Vol. 89, No. 21, 2017, p. 2126-2127.Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Neurofilaments in blood
T2 - (Almost) facing clinical application
AU - Mielke, Michelle M.
AU - Otto, Markus
N1 - Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden- Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures. Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden-Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures.
PY - 2017
Y1 - 2017
UR - http://www.scopus.com/inward/record.url?scp=85044043771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044043771&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000004675
DO - 10.1212/WNL.0000000000004675
M3 - Editorial
C2 - 29070663
AN - SCOPUS:85044043771
VL - 89
SP - 2126
EP - 2127
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 21
ER -